News
Moderna Announces Amendment to Supply Agreement with the Ministry of Health of Israel to Supply Additional Doses of mRNA Vaccine Against COVID-19
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced an expanded supply agreement with the Ministry of Health of Israel for an additional 4 million...
News
Amgen and McKesson Launch Strategic Agreement to Advance Cancer Innovation in Communities
McKesson and Amgen, one of the world’s leading biotechnology companies, have signed a strategic agreement to help improve cancer care in community oncology settings. Today, 1 in 5 cancer patients receives an Amgen medicine, while McKesson reaches 20% of...
Clinical Trials
Kaneka Eurogentec will manufacture INOVIO’s DNA vaccine candidate against COVID-19
INOVIO has assembled a global coalition of collaborators, partners and funders to rapidly advance the development of INO-4800, a DNA vaccine against the novel coronavirus SARS-CoV-2.
INOVIO’s President & CEO, Dr. J. Joseph Kim, said, “Our partnership with Kaneka Eurogentec,...
Drug Research
Lilly and UnitedHealth Group partner on pragmatic study of neutralizing antibody bamlanivimab for COVID-19
Eli Lilly and Company and UnitedHealth Group announced a partnership to conduct a pragmatic study of bamlanivimab (LY-CoV555) in high-risk, COVID-19 infected individuals.
Bamlanivimab recently received EUA by the U.S. FDA for the treatment of mild to moderate COVID-19 patients...
Drug Research
Rush For A COVID Vaccine- Is It Science Or Politics…?
COVID-19 vaccine usage announcement by the UK has brought us to the brink where other countries too might jump on the bandwagon. Is it safe or are we rushing into things? We only hope that science triumphs over politics.
Are...
News
Samsung Biologics drives digital transformation with Plant 4 Virtual Showroom launch
Samsung Biologics announced the launch of a virtual showroom to provide key features and real-time construction updates of its recently announced Plant 4. The digital showcase also highlights various specs and services that the Super Plant will offer upon...
News
Gerresheimer: Syringes for Biotechnologically Manufactured Active Ingredients
Biotechnologically manufactured active ingredients demonstrate a series of special features. Some are highly viscous, concentrated and in individual cases, tend to interact with silicone oil or, for example, tungsten residue from syringe production. Gerresheimer Biologcial Solutions offers a special...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read